A Pilot Efficacy and Safety Study of ST101 in Essential Tremor

Summary

This study will look at the ability of ST101 to treat symptoms in subjects with Essential Tremor. This study will also examine the safety and tolerability of the drug. This study is evaluating one dose level of ST101 versus placebo in a cross-over fashion. This means that all patients will receive both ST101 and placebo, but they will receive it in a random (by chance) order.

Timeline

Start

2011-04

Primary completion

2011-12

Completion

2011-12

Drugs

Indications